Accelerated partial-breast irradiation vs conventional whole-breast radiotherapy in early breast cancer: A case-control study of disease control, cosmesis, and complications

Journal of Cancer Research and Therapeutics

Volumn 5, Issue 2, 2009, Pages 93-101

  Wadasadawala, Tabassum ^a   Sarin, Rajiv ^a   Budrukkar, Ashwini ^a   Jalali, Rakesh ^a   Munshi, Anusheel ^a   Badwe, Rajendra ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Accelerated partial breast irradiation; American brachytherapy society; Early breast cancer; Interstitial brachytherapy; Whole breast radiotherapy

Indexed keywords

ADULT; ARM EDEMA; ARTICLE; BREAST CANCER; BREAST FIBROSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CASE CONTROL STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE CONTROL; DISEASE FREE SURVIVAL; FAT NECROSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; RADIATION DOSE; STATISTICAL SIGNIFICANCE; TELANGIECTASIA; TUMOR VOLUME;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MIDDLE AGED; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 67749127873     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.52794     Document Type: Article

References (44)

1. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 1996;88:1659-64.
2. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabár L, Nordgren H, et al. 10 year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 1999;17:2326-33.
3. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast conserving surgery in small breast carcinoma: Long term results of a randomized trial. Ann Oncol 2001;12:997-1003.
4. Morrow M, White J, Moughan J, Owen J, Pajack T, Sylvester J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 2001;19: 2254-62.
5. Ohtake T, Abe R, Kimijima I, Fukushima T, Tsuchiya A, Hoshi K, et al. Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Cancer 1995;76:32-45.
6. Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005;75:9-17.
7. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, et al. Effect of radiotherapy fraction size on tumor control in patients with early stage breast cancer after local tumor exicision: long term results of a randomized trial. Lancet Oncology 2006;7:467-71.
8. No authors listed: Standardisation of Breast Radiotherapy (START) trial. START trial management group. Clin Oncol 1999;11:145-7.
9. Sarin R. Partial breast treatment for early breast cancer: emergence of a new paradigm. Nature Clinical Practice Oncology 2004, Vol 2, No. 1, 40-47.
10. Budrukkar A, Sarin R, Jalali R, Badwe R, Parmar V, Nadkarni M et al. APBI with interstitial brachytherapy as a sole modality of radiation for women with low risk early stage breast cancer, JCO, 2006, ASCO Proceedings, vol. 24, no. 18S, 10661.
11. Arthur DW, Vicini FA, Kuske RR, Wazer DE, Nag S; American Brachytherapy Society. Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy 2003;2:124-30.
12. American Society of Breast Surgeons. Consensus statement for accelerated partial breast irradiation. Available from: http://www. breastsurgeons.org/ officialstmts/ officialstmt3.shtml. [last accessed Jun 2008].
13. Kuske RR, Winter K, Arthur DW, Bolton J, Rabinovitch R, White J, et al. Phase II of brachytherapy alone after lumpectomy for select breast cancer: Toxicity analysis of RTOG 95-17. Int J Radiati0on Oncology Biol Phys 2006;65:45-51.
14. Harris JR, Levene MB, Svensson G, Hellman S. Analysis of cosmetic results following primary radiation therapy for stage I and II breast carcinoma. Int J Radiat Oncol Biol Phys 1979;5:257-61.
15. Polgár C, Sulyok Z, Fodor J, Orosz Z, Major T, Takácsi-Nagy Z, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 2002;80:121-8.
16. Polgár C, Major T, Fodor J, Németh G, Orosz Z, Sulyok Z, et al. High dose rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast conserving surgery: Seven year results of a comparative study. Int J Radiat Oncol Biol Phys 2004;6:1173-81.
17. Polgar C, Strnad V, Major T. Brachytherapy for partial breast irradiation: the European experience. Semin Radiat Oncol 2005;15:116-22.
18. Kuerer H. The case for accelerated partial breast irradiation for breast cancer. Contemporary Surgery 2003;59:508-17.
19. Vaidya JS, Tobias JS, Baum M, Keshtgar M, Joseph D, Wenz F, et al. Intraoperative radiotherapy for breast cancer. Lancet Oncol 2004;5:165-73.
20. Tobias JS, Vaidya JS, Keshtgar M, D'Souza DP, Baum M. Reducing radiotherapy dose early breast cancer: the concept of conformal Intraoperative brachytherapy. Br J Radiol 2004;77:279-84.
21. Wallner P, Arthur D, Bartelink H, Connolly J, Edmundson G, Giuliano A, et al. Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8-10, 2002. J Natl Cancer Inst 2004;96:175-84.
22. Orecchia R, Ciocca M, Lazzari R, Garibaldi C, Leonardi MC, Luini A, et al: Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. Breast 2003;12:483-90.
23. Vicini F, Baglan K, Kestin L, Mitchell C, Chen P, Frazier R et al. Accelerated treatment of breast cancer. J Clin Oncol 2001;19:1993-2001.
24. Kuske R, Bolton J, Fuhrman G, McKinnon W, Stolier A, Wilenzick R, et al. Wide volume brachytherapy alone for select breast cancers: the ten year experience of the Ochsner Clinic. Int J Radiat Oncol Biol Phys 2000;48:296. (abstr, suppl 3).
25. Benitez PR, Chen PY, Vicini FA, Wallace M, Kestin L, Edmundson G, et al. Partial breast irradiation in breast-conserving therapy by way of interstitial brachytherapy. The American Journal of Surgery 2004;18:355-64.
26. Polgár C, Major T, Somogyi A, Fodor J, Tóth J, Sulyok Z, et al. Sole brachytherapy of the tumor bed after breast-conserving surgery: A new radiotherapeutic strategy for patients at low risk of local relapse. Neoplasma 1999;46:182-9.
27. Arthur DW, Koo D, Zwicker RD, Tong S, Bear HD, Kaplan BJ, et al. Partial breast brachytherapy after lumpectomy: Low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys 2003;56:681-9.
28. rd edn. London: Arnold;2002:134-46.
29. Magee B, Swindell R, Harris M, Banerjee SS. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial. Radiother Oncol 1996;39;223-7.
30. Fentiman IS, Poole C, Tong D, Winter PJ, Gregory WM, Mayles HM, et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer 1996;32A:608-11.
31. Poccti Z, Nemeskéri C, Fekésházy A, Sáfrány G, Bajzik G, Nagy ZP, et al. Partial breast irradiation with interstitial 60Co brachytherapy results in frequent grade 3 or 4 toxicity: evidence based on a 12-year follow-up of 70 patients. Int J Radiat Oncol Biol Phys 2004;58:1022-33.
32. Perera F, Yu E, Engel J, Holliday R, Scott L, Chisela F, et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up. Int J Radiat Oncol Biol Phys 2003;57:1239-46.
33. Berle L, Wazer D, Graham R, et al.: Toxicity, local control and cosmesis after interstitial partial breast HDR brachytherapy alone for T1/T2 breast cancer. Radiother Oncol 2004; 71:74, (abstr, suppl).
34. Krishnan L, Jewell WR, Tawfik OW, Krishnan EC. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J 2001;7:91-6.
35. Wazer DE, Berle L, Graham R, Chung M, Rothschild J, Graves T, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 2002;53:889-97.
36. Sarin R, Dinshaw KA, Shrivastava SK, Sharma V, Deore SM. Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early breast cancer. Int J Radiat Oncol Biol.Phys 1993;27:285-92.
37. Limbergen E, Mazeron J GEC-ESTRO guidelines for breast cancer brachytherapy: 445-454.
38. Li C, Wilson PB, Levine E, Barber J, Stewart AL, Kumar S. TGF-β1levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer (Pred. Oncol), 1999;84:155-9.
39. Veronesi A, de Giacomi C, Magri MD, Lombardi D, Zanetti M, Scuderi C, et al. Familial breast cancer: Characteristics and outcome of BRCA 1-2 positive and negative cases. BMC Cancer 2005;5:70.
40. Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004;187:69-72.
41. Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: Results of the sentinellae GIVOM Italian randomised clinical trial. Eur J Surg Oncol 2008;34:508-13.
42. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609.
43. Deutsch M, Land S, Begovic M, Sharif S. The incidence of arm edema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. Int J Radiat Oncol Biol Phys 2008;70-1020-4.
44. Keisch M, Vicini F, Scroggins T, Hebert M, White J, Kuske R, et al. J. Thirty-Nine Month Results with the MammoSite Brachytherapy Applicator: Details Regarding Cosmesis, Toxicity and Local Control in Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 2005; Volume 63, Number 2, S6(10).